Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas B Norgard

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Therapeutic Advances in Chronic Disease|December 20, 2012
Novel anticoagulants in atrial fibrillation stroke preventionNicholas B Norgard, James J Dinicolantonio, Taylor J Topping, et al.
Cardiovascular Therapeutics|April 27, 2017
Aspirin responsiveness changes in obese patients following bariatric surgeryNicholas B Norgard, Scott V Monte, Stanley F Fernandez, et al.
Current Heart Failure Reports|June 8, 2023
Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure ManagementKhalid Sawalha, Nicholas B Norgard, Betty M Drees, et al.
Thrombosis and Haemostasis|June 12, 2010
The in vitro effects of niacin on platelet biomarkers in human volunteersVictor Serebruany, Alex Malinin, Daniel Aradi, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterizationNicholas B Norgard, S Saya, C L Hann, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin ExposureJustin R Lenhard, Tanya Brown, Michael J Rybak, et al.
Pharmacotherapy|November 26, 2016
The Importance of Research and Scholarly Activity in Pharmacy TrainingEli N Deal, Paul M Stranges, Whitney D Maxwell, et al.
Future Cardiology|April 26, 2014
Optimal aspirin dose in acute coronary syndromes: an emerging consensusJames J DiNicolantonio, Nicholas B Norgard, Pascal Meier, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Therapeutic Advances in Chronic Disease|December 20, 2012
Novel anticoagulants in atrial fibrillation stroke preventionNicholas B Norgard, James J Dinicolantonio, Taylor J Topping, et al.
Cardiovascular Therapeutics|April 27, 2017
Aspirin responsiveness changes in obese patients following bariatric surgeryNicholas B Norgard, Scott V Monte, Stanley F Fernandez, et al.
Current Heart Failure Reports|June 8, 2023
Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure ManagementKhalid Sawalha, Nicholas B Norgard, Betty M Drees, et al.
Thrombosis and Haemostasis|June 12, 2010
The in vitro effects of niacin on platelet biomarkers in human volunteersVictor Serebruany, Alex Malinin, Daniel Aradi, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterizationNicholas B Norgard, S Saya, C L Hann, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin ExposureJustin R Lenhard, Tanya Brown, Michael J Rybak, et al.
Pharmacotherapy|November 26, 2016
The Importance of Research and Scholarly Activity in Pharmacy TrainingEli N Deal, Paul M Stranges, Whitney D Maxwell, et al.
Future Cardiology|April 26, 2014
Optimal aspirin dose in acute coronary syndromes: an emerging consensusJames J DiNicolantonio, Nicholas B Norgard, Pascal Meier, et al.
Pageof 3